These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 11068248)

  • 1. Endovascular brachytherapy of transjugular intrahepatic portosystemic shunt.
    Dvorák J; Hůlek P; Raupach J; Vanásek T; Petera J; Krajina A; Vanásek J; Zoul Z; Odrázka K; Lojík M; Masková J; Safka V; Vodnansky P; Fridrich J
    Cardiovasc Radiat Med; 2001 Jan; 2(1):3-6. PubMed ID: 11068248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endovascular brachytherapy of transjugular intrahepatic portosystemic shunt.
    Dvorák J; Hůlek P; Raupach J; Vanásek T; Petera J; Krajina A; Vanásek J; Zoul Z; Odrázka K; Lojík M; Masková J; Safka V; Vodnanský P; Fridrich J
    Cardiovasc Radiat Med; 2000; 2(1):3-6. PubMed ID: 11229059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five year follow-up after brachytherapy for restenosis in peripheral arteries.
    Liermann DD; Bauernsachs R; Schopohl B; Böttcher HD
    Semin Interv Cardiol; 1997 Jun; 2(2):133-7. PubMed ID: 9546994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endovascular brachytherapy in coronary arteries: the Rotterdam experience.
    Coen VL; Knook AH; Wardeh AJ; van der Giessen WJ; De Pan C; Sipkema D; Marijnissen JP; Sabaté M; den Boer A; Serruys PW; Levendag PC
    Cardiovasc Radiat Med; 2000; 2(1):42-50. PubMed ID: 11229062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraluminal 192Ir brachytherapy following transjugular intrahepatic portosystemic shunt revision: long-term results and radiotherapy parameters.
    Pokrajac B; Cejna M; Kettenbach J; Schamp S; Fellner C; Seitz W; Lammer J; Poetter R
    Cardiovasc Radiat Med; 2001; 2(3):133-7. PubMed ID: 11786318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ePTFE-covered stent-grafts for revision of obstructed transjugular intrahepatic portosystemic shunt.
    Cejna M; Peck-Radosavljevic M; Thurnher S; Schoder M; Rand T; Angermayr B; Lammer J
    Cardiovasc Intervent Radiol; 2002; 25(5):365-72. PubMed ID: 11981612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endovascular brachytherapy in coronary arteries: the Rotterdam experience.
    Coen VL; Knook AH; Wardeh AJ; van der Giessen WJ ; De Pan C ; Sipkema D; Marijnissen JP; Sabaté M; den Boer A ; Serruys PW; Levendag PC
    Cardiovasc Radiat Med; 2001 Jan; 2(1):42-50. PubMed ID: 11068255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility and safety of intra-coronary Beta irradiation with 144Ce/Pr for prevention of restenosis after percutaneous transluminal coronary angioplasty of in-stent restenotic lesions.
    Bonvini RF; Hendiri T; Leo G; Aeby N; Noble J; Sigwart U; Verin V
    Acute Card Care; 2006; 8(4):217-23. PubMed ID: 17162548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraluminal brachytherapy of de novo TIPS: a prospective randomized double-blind study.
    Hidajat N; Stupavsky A; Gellermann J; Kreuschner M; Stahl H; Wust P; Felix R; Schroeder RJ
    AJR Am J Roentgenol; 2006 Apr; 186(4):1133-7. PubMed ID: 16554592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is sonographic surveillance of polytetrafluoroethylene-covered transjugular intrahepatic portosystemic shunts (TIPS) necessary? A single centre experience comparing both types of stents.
    Pan JJ; Chen C; Geller B; Firpi R; Machicao VI; Caridi JG; Nelson DR; Morelli G
    Clin Radiol; 2008 Oct; 63(10):1142-8. PubMed ID: 18774362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanded PTFE-covered stent-grafts in the treatment of transjugular intrahepatic portosystemic shunt (TIPS) stenoses and occlusions.
    Echenagusia M; Rodriguez-Rosales G; Simo G; Camuñez F; Bañares R; Echenagusia A
    Abdom Imaging; 2005; 30(6):750-4. PubMed ID: 16245017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endovascular brachytherapy in the prevention of vascular restenosis.
    Dvorák J; Fridrich J; Raupach J; Petera J; Krajina A; Lojík M; Masková J; Vodnanský P; Zoul Z; Odrázka K; Kalousová D; Chovanec V
    Cardiovasc Radiat Med; 2001; 2(3):130-2. PubMed ID: 11786317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracoronary brachytherapy for the prevention of restenosis after percutaneous coronary revascularization.
    Sheppard R; Eisenberg MJ; Donath D; Meerkin D
    Am Heart J; 2003 Nov; 146(5):775-86. PubMed ID: 14597925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High dose rate endovascular brachytherapy in aorto-iliac lesion for the prevention of restenosis.
    Yamazaki H; Tomoda K; Shiomi H; Maeda M; Kawata S; Okada A; Murakami T; Nakamura H; Tanaka E; Inoue T; Inoue T
    Radiat Med; 2002; 20(1):25-32. PubMed ID: 12002600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Phase II study of external-beam radiotherapy and endovascular brachytherapy with PTA and stenting for femoropopliteal artery restenosis.
    Narayan K; Denton M; Das R; Bernshaw D; Rolfo A; van Dyk S; Mirakian A
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):238-43. PubMed ID: 16820271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of a polytetrafluoroethylene-covered stent graft for transjugular intrahepatic portosystemic shunt (TIPS): Long-term follow-up of 100 patients.
    Rössle M; Siegerstetter V; Euringer W; Olschewski M; Kromeier J; Kurz K; Langer M
    Acta Radiol; 2006 Sep; 47(7):660-6. PubMed ID: 16950701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracoronary beta-radiation for the treatment of patients at very high risk for recurrence of in-stent restenosis: a single center experience.
    Parenti DZ; Marsico F; Tosi G; Catalano G; Maiello L; Milone F; Carcagnì A; Pron PG; Orecchia R; Presbitero P
    Ital Heart J; 2003 Mar; 4(3):199-204. PubMed ID: 12784747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta endovascular brachytherapy using CO2-filled centering catheter for treatment of recurrent superficial femoropopliteal artery disease.
    Pokrajac B; Kirisits C; Schmid R; Schillinger M; Berger D; Peer K; Tripuraneni P; Pötter R; Minar E
    Cardiovasc Revasc Med; 2009; 10(3):162-5. PubMed ID: 19595397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension using memotherm stents: a prospective multicenter study.
    Domagk D; Patch D; Dick R; Grosso M; Rousseau H; Otal P; Goffette P; Heinecke A; Drees M; Domschke W; Menzel J
    Cardiovasc Intervent Radiol; 2002; 25(6):506-12. PubMed ID: 12183763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.